Human Epithelial Ovarian Cancer Cells Expressing CD105, CD44 and CD106 Surface Markers Exhibit Increased Invasive Capacity and Drug Resistance

Oncology Letters - Greece
doi 10.3892/ol.2019.10221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Downregulation of Vimentin Expression Increased Drug Resistance in Ovarian Cancer Cells

Oncotarget
Oncology
2016English

Stem-Like and Highly Invasive Prostate Cancer Cells Expressing CD44v8-10 Marker Originate From CD44-negative Cells

Oncotarget
Oncology
2018English

Cancer-Initiating Cells Derived From Established Cervical Cell Lines Exhibit Stem-Cell Markers and Increased Radioresistance

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Breast Cancer Cells Expressing Stem Cell Markers CD44+ CD24lo Are Eliminated by Numb-1 Peptide-Activated T Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2008English

Increased Invasion and Tumorigenicity Capacity of CD44+/CD24- Breast Cancer McF7 Cells in Vitro and in Nude Mice

Cancer Cell International
Cancer ResearchOncologyGenetics
2013English

Coumestrol Suppresses Proliferation of ES2 Human Epithelial Ovarian Cancer Cells

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2015English

MicroRNA-200c Overexpression Inhibits Tumorigenicity and Metastasis of CD117+CD44+ Ovarian Cancer Stem Cells by Regulating Epithelial-Mesenchymal Transition

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

CD44+ Gastric Cancer Cells With Stemness Properties Are Chemoradioresistant and Highly Invasive

Oncology Letters
Cancer ResearchOncology
2013English

Fourier Transform Infrared Spectroscopy Monitoring of Dihydroartemisinin-Induced Growth Inhibition in Ovarian Cancer Cells and Normal Ovarian Surface Epithelial Cells

Cancer Management and Research
Oncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy